Success of Rhabdomyosarcoma Treatment in Children

Including Rarer Types of RMS Disease in AdultsByJaime R. Herndon, MS, MPHPublished on July 03, 2023Medically reviewed byDoru Paul, MDRhabdomyosarcomais a kind ofsar

Updated on: November 21,2023 56

Success of Rhabdomyosarcoma Treatment in Children

Including Rarer Types of RMS Disease in AdultsByJaime R. Herndon, MS, MPHPublished on July 03, 2023Medically reviewed byDoru Paul, MDRhabdomyosarcomais a kind ofsar

Updated on:November 21,2023 56

Divarasib Displays Early-Phase Activity in KRAS G12C–Mutant Solid Tumors

September 5, 2023Kyle DohertyTreatment with the KRAS G12C inhibitor divarasib (formerly GDC-6036)led to durable responses with a tolerable safety profile in patients with a variety of solid tumo

Updated on: October 12,2023 22

Divarasib Displays Early-Phase Activity in KRAS G12C–Mutant Solid Tumors

September 5, 2023Kyle DohertyTreatment with the KRAS G12C inhibitor divarasib (formerly GDC-6036)led to durable responses with a tolerable safety profile in patients with a variety of solid tumo

Updated on:October 12,2023 22

Single set of criteria to assess progression in glioma aims to speed discovery of new medicines

byDana-Farber Cancer InstituteInfant high-grade glioma. Credit: David Ellison, St. Jude Children’s Research HospitalIn order to accurately assess the efficacy of novel therapies for brain tumors

Updated on: October 31,2023 10

Single set of criteria to assess progression in glioma aims to speed discovery of new medicines

byDana-Farber Cancer InstituteInfant high-grade glioma. Credit: David Ellison, St. Jude Children’s Research HospitalIn order to accurately assess the efficacy of novel therapies for brain tumors

Updated on:October 31,2023 10

New antibody may offer effective drug treatment for breast cancer

An enzyme that may help some breast cancers spread can be stopped with an antibody created in the lab of Cold Spring Harbor Laboratory Professor Nicholas Tonks. With further development, the antibody

Updated on: October 31,2023 12

New antibody may offer effective drug treatment for breast cancer

An enzyme that may help some breast cancers spread can be stopped with an antibody created in the lab of Cold Spring Harbor Laboratory Professor Nicholas Tonks. With further development, the antibody

Updated on:October 31,2023 12

Can Artificial Intelligence–Driven Chatbots Correctly Answer Questions about Cancer?

by Edward WinsteadArtificial intelligence (AI) technologies have become part of everyday life for many people, helping with mundane tasks such as shopping online and using social media. But can AI-dri

Updated on: October 15,2023 40

Can Artificial Intelligence–Driven Chatbots Correctly Answer Questions about Cancer?

by Edward WinsteadArtificial intelligence (AI) technologies have become part of everyday life for many people, helping with mundane tasks such as shopping online and using social media. But can AI-dri

Updated on:October 15,2023 40

Common genetic defect in prostate cancer inspires path to new anti-cancer drugs

byTemple UniversityCredit: CC0 Public DomainLike security screening to make sure nothing harmful makes its way into a crowded area, cells in the human body use checkpoints to control their growt

Updated on: December 20,2023 18

Common genetic defect in prostate cancer inspires path to new anti-cancer drugs

byTemple UniversityCredit: CC0 Public DomainLike security screening to make sure nothing harmful makes its way into a crowded area, cells in the human body use checkpoints to control their growt

Updated on:December 20,2023 18

NXC-201 Demonstrates Feasibility of BCMA-Directed CAR T-Cell Therapy in Relapsed/Refractory AL

September 30, 2023Ryan Scotthe novel anti-BCMA CAR T-cell therapy NXC-201 displayed safety and elicited hematologic and organ responses in patients with relapsed/refractory amyloid light chain amyloid

Updated on: October 24,2023 267

NXC-201 Demonstrates Feasibility of BCMA-Directed CAR T-Cell Therapy in Relapsed/Refractory AL

September 30, 2023Ryan Scotthe novel anti-BCMA CAR T-cell therapy NXC-201 displayed safety and elicited hematologic and organ responses in patients with relapsed/refractory amyloid light chain amyloid

Updated on:October 24,2023 267

NCCN releases new resources to improve quality of life for people with cancer

The National Comprehensive Cancer Network®(NCCN®) is announcing new resources focused on improving quality of life for people with cancer while making sure care planning reflects individual need

Updated on: October 31,2023 10

NCCN releases new resources to improve quality of life for people with cancer

The National Comprehensive Cancer Network®(NCCN®) is announcing new resources focused on improving quality of life for people with cancer while making sure care planning reflects individual need

Updated on:October 31,2023 10

Impact of epigenetics on the clinical management of cancer patients

byJosep Carreras Leukaemia Research InstituteClinical applications of epigenetic biomarkers. Cancer specificity of the epigenetic profiles generated not only from tumor tissues (solid biopsies)

Updated on: December 19,2023 10

Impact of epigenetics on the clinical management of cancer patients

byJosep Carreras Leukaemia Research InstituteClinical applications of epigenetic biomarkers. Cancer specificity of the epigenetic profiles generated not only from tumor tissues (solid biopsies)

Updated on:December 19,2023 10

Liver cancer: Risk factors and prevention

by Laurel Kelly,Mayo ClinicCredit: Pixabay/CC0 Public DomainOctober is Liver Cancer Awareness Month, which makes this a good time to learn more about risk factors for liver cancer and what you c

Updated on: October 31,2023 10

Liver cancer: Risk factors and prevention

by Laurel Kelly,Mayo ClinicCredit: Pixabay/CC0 Public DomainOctober is Liver Cancer Awareness Month, which makes this a good time to learn more about risk factors for liver cancer and what you c

Updated on:October 31,2023 10

IMNN-001 Plus Neoadjuvant Chemotherapy Improves PFS in Advanced Ovarian Cancer

September 28, 2023Chris RyanTreatment with the interleukin-12 gene-mediated immunotherapy IMNN-001 in combination with neoadjuvant platinum chemotherapy led to an improvement in progression-free survi

Updated on: October 10,2023 280

IMNN-001 Plus Neoadjuvant Chemotherapy Improves PFS in Advanced Ovarian Cancer

September 28, 2023Chris RyanTreatment with the interleukin-12 gene-mediated immunotherapy IMNN-001 in combination with neoadjuvant platinum chemotherapy led to an improvement in progression-free survi

Updated on:October 10,2023 280

ctDNA Could Serve as a Prognostic Tool in China for Predicting Outcomes in DLBCL

September 12, 2022Lisa AstorResults from a retrospective analysis presented during the 2022 ESMO Congress indicated that circulating tumor DNA could potentially be leveraged as a prognostic factor and

Updated on: October 24,2023 42

ctDNA Could Serve as a Prognostic Tool in China for Predicting Outcomes in DLBCL

September 12, 2022Lisa AstorResults from a retrospective analysis presented during the 2022 ESMO Congress indicated that circulating tumor DNA could potentially be leveraged as a prognostic factor and

Updated on:October 24,2023 42